about
A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal StudySpeckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats.Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolismVS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.Cardiorenal syndrome and vitamin D receptor activation in chronic kidney diseaseThe influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis StudyProtective cardiovascular and renal actions of vitamin D and estrogenVitamin D and the heart.Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.Diabetic microvascular complications: possible targets for improved macrovascular outcomesVitamin D receptor activation and cardiovascular disease.Vitamin D and the cardiovascular system: an overview of the recent literature.Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis.Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria.Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis.
P2860
Q30381312-75EA1ABB-A860-41E5-B6E7-B065323E537BQ30401905-0EE04833-B990-488A-B53C-A3D636FDFDE5Q34475608-EDEAA070-8839-493A-BFDF-36B98F58EA15Q34719267-16F29BEE-7B7A-4DED-BFF0-A4A8812C4DC7Q35287391-E98FD08F-C5DA-4AB6-9394-DFDBD9E6D644Q35667633-3E906261-665D-441F-9601-1B7BA3D528D6Q36468531-102D4B32-9A58-4160-A411-73C951882699Q36613869-861503FD-EDDD-4993-9E26-E035F5F79196Q36770929-07208896-DEF4-4150-9E98-F003D43E4018Q36905627-7DE7D190-21D8-4807-8721-EF8740817465Q37342339-426D83D5-F4F2-49F2-A6A0-7B98056C405EQ37520430-7C6C0411-A599-460B-B5EE-5BC5576CBA20Q37690771-EC402A50-871A-4C7C-881B-3973462FC03BQ37892915-1CCDDE07-8953-4DC5-A004-199A9F3859D5Q38069143-F35CC2C5-6E2E-47B6-B80A-408D955C42AFQ38152318-AC6520E6-CD2A-4322-92D5-D869F6444B13Q38258133-2E4E37C3-1BF8-47B6-9C3D-357156A96C85Q46290245-A3CB3C84-5D54-4ED5-B783-857A1814516DQ49061065-F874848D-82B6-47CD-9AFC-E60B16B5C599Q50433834-308B8058-4B09-4D06-B76F-595DA74BBA89Q51025922-C9E9F015-DDD8-4316-91BA-1B31F75402C0
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Myocardial effects of VDR activators in renal failure
@ast
Myocardial effects of VDR activators in renal failure
@en
Myocardial effects of VDR activators in renal failure
@nl
type
label
Myocardial effects of VDR activators in renal failure
@ast
Myocardial effects of VDR activators in renal failure
@en
Myocardial effects of VDR activators in renal failure
@nl
prefLabel
Myocardial effects of VDR activators in renal failure
@ast
Myocardial effects of VDR activators in renal failure
@en
Myocardial effects of VDR activators in renal failure
@nl
P2093
P2860
P1476
Myocardial effects of VDR activators in renal failure
@en
P2093
Eduardo Slatopolsky
Helen Liapis
Hironori Nakamura
Jane Finch
Jeremiah Morrissey
Masahide Mizobuchi
Masanori Tokumoto
P2860
P304
P356
10.1016/J.JSBMB.2010.03.026
P577
2010-03-15T00:00:00Z